Clinical trials show that most people regain weight after stopping GLP-1 medications, with approximately two-thirds of lost weight returning within a year
In recent developments, the FDA further expanded semaglutides indication to include reducing the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease who are either obese or overweight
It offers growth hormones that aid muscle development and improve recovery
It exists as a research chemical, and it is only available for research purposes
Others report no meaningful change, and at least one person who lost 120 pounds on the medication reported that their fibromyalgia symptoms actually intensified rather than improved, which rather pokes a hole in the simple weight loss hypothesis
03 Burning or stinging at the injection site This usually means the solution is too cold (just out of the fridge) or was injected too quickly